DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

CORONA Remedies Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·22 Jul 2026, 9:03 am

Corona Remedies

Corona Remedies Limited has announced the schedule for its upcoming analyst and institutional investor meet. The company will host a conference call to discuss its business performance, future strategy, and operational outlook with market participants.

This meeting is significant for investors as it provides a direct platform to understand the management's view on the company's growth trajectory and address investor queries. It offers transparency and clarity, which are essential for making informed investment decisions.

Investors should watch for updates on the company's financial health, product pipeline, and any strategic initiatives discussed during the call. These insights will be crucial for assessing the company's potential in the coming quarters.